Eleven cyclic diarylheptanoids and seven related compounds were screened as potential antitumor promoters by using the in vitro short-term 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced Epstein–Barr virus early antigen (EBV-EA) activation assay. In addition, the cyclic diarylheptanoid myricanone (2) was examined for antitumor initiating activity in a two- stage carcinogenesis assay of mouse skin tumors induced by peroxynitrite as an initiator ...
[Mouterde, Louis M. M.; Flourat, Amandine L.; Cannet, Molly M. M.; Ducrot, Paul-Henri; Allais, Florent European Journal of Organic Chemistry, 2013 , # 1 p. 173 - 179]